[Sci-all-l] Chem Lecture: Why Drugs Fail, Nov 3
Kam Dahlquist
kadahlquist at vassar.edu
Mon Nov 1 11:20:20 EST 2004
Chemistry Lecture
TITLE: Why Drugs Fail?
Speaker: Dr. Josh Bloom
Wyeth Pharmaceuticals
Date: November 3, 2004
Time: 4 PM, refreshments 3:30
Place: SciVis Lab
ABSTRACT
Life in pharmaceutical research is pretty tough. Most organic chemists will
spend their entire career without ever getting a drug on the market. In
fact, simply getting something into human clinical trials is considered to
be a home run, despite the fact that even at this stage about 9 in 10
compounds will eventually fail.
This seminar examines a number of major projects I have worked on or led.
It compares older ways of drug development with newer methods that increase
the likelihood that compounds will be more "druglike" and thus have a
higher probability for success. Much of this research has been in the area
of virology, and I will devote considerable time to basic virology concepts
and the importance of research in this area.
I will also take a (very) critical look at past failures (and some
successes) and discuss the reasons for the failures. Part of this is, of
course, technical-- the inability of cell-based and animal models to always
predict human disease therapies. But a surprisingly "good" portion of the
failures can also be attributed to human faults, usually politics, ego and
good old-fashioned stupidity. And if you think the latter won't be
mentioned (and ridiculed) you would be mistaken. Not for the humorless.
******************************************
Kam D. Dahlquist, Ph.D.
Assistant Professor of Biology
Vassar College, Box 516
124 Raymond Avenue
Poughkeepsie, NY 12604-0516
Tel: 845-437-5266
Fax: 845-437-7315
E-mail: kadahlquist at vassar.edu
******************************************
More information about the Sci-all-l
mailing list